黑料吃瓜群网

has launched what is reported to be Australia鈥檚 first accredited surgical face mask testing facility in Melbourne.

The new facility, accredited by the (NATA), has the capacity to provide a rapid turnaround on surgical face mask testing, helping manufacturers fast-track the supply of masks for frontline healthcare workers.

To gain NATA accreditation, the CSIRO facility underwent rigorous on-site assessments to ensure it could provide tests that show single-use surgical masks adequately filter biological particles, resist blood penetration and enable the wearer to breathe comfortably. Manufacturers that pass all three tests will meet both Australian and international standards and can be registered on the Australian Register for Therapeutic Goods.

The launch is also a boost for Australian companies who will not need to send masks and materials overseas for testing.

鈥淚t鈥檚 inspiring to see Australian science enabling Australian businesses to supply life-saving surgical face masks to protect our frontline health care workers 鈥� yet another way science is tackling the COVID-19 pandemic,鈥� CSIRO Chief Executive Dr Larry Marshall said.

鈥淭his new facility will give Aussie businesses another solution from science to stop the spread of COVID-19 and save lives.

鈥淪cience is guiding us through COVID-19, and science will help us grow on the other side. There鈥檚 not much Aussie innovation can鈥檛 solve, whether it鈥檚 finding the right vaccine or creating Australia鈥檚 first NATA-accredited face mask testing facility.鈥�

Manufacturers can use test results obtained at the CSIRO facility to demonstrate that the performance of their medical masks is suitable for supplying Australian hospitals, as well as contributing to the global pandemic response.

Queensland manufacturer has recently pivoted to mask manufacturing to help meet Australia鈥檚 COVID-19 PPE demands. Evolve Managing Director Ty Hermans said the new testing facility will support the company in getting its masks to where they鈥檙e needed faster.

鈥淯sing CSIRO鈥檚 Australian testing facility means we don鈥檛 have to ship our masks overseas, which saves us time and money,鈥� Hermans said.

鈥淚t has been our mission to reshore manufacturing ever since we started in 2006.

鈥淭esting our face masks at CSIRO鈥檚 facility aligns with our goal to bolster Australia鈥檚 sovereign manufacturing capability and not have to rely on overseas facilities.

鈥淓volve Group is confident in the product we have designed and we鈥檙e now looking forward to CSIRO testing our masks to ensure they meet stringent Australian standards and can provide critical protection to frontline workers.鈥�

A scientist performs a blood penetration test by testing masks for resistance to synthetic blood penetration. 漏Nick Pitsas